Author:
Tu YP,Jennings R,Hart B,Cangelosi GA,Wood RC,Wehber K,Verma P,Vojta D,Berke EM
Abstract
ABSTRACTBackgroundCurrent testing for SARS-CoV-2 requires health care workers to collect a nasopharyngeal (NP) sample from a patient. NP sampling requires the use of personal protective equipment that are in limited supply, is uncomfortable for the patient, and reduces clinical efficiency. This study explored the equivalency of patient-collected tongue, anterior nares (nasal), and mid-turbinate (MT) samples to health care worker-collected NP samples for detecting SARS-CoV-2.MethodsPatients presenting to five urgent care facilities with symptoms indicative of an upper respiratory infection provided self-collected samples from three anatomic sites along with a health care worker-collected NP sample. Using NP as the comparator, sensitivities and one-sided 95% confidence intervals for the tongue, nasal, and MT samples for detection of SARS-CoV-2 were calculated.ResultsThe sensitivity for detecting SARS-CoV-2 in patient-collected tongue, nasal, and mid-turbinate samples was 89.8% (95% CI: 80.2 -100.0), 94.0 (95% CI: 84.6-100.0) and 96.2 (95% CI: 87.7-100.0), respectively. Among samples yielding positive results, cycle threshold (Ct) values (a measure of viral load) had correlation coefficients of 0.48, 0.78, and 0.86 between the NP samples and the tongue, nasal, and MT samples, respectively.ConclusionsPatient-collected nasal and MT samples demonstrated high sensitivity for SARS-CoV-2 detection using health care worker-collected NP samples as the comparator. Among patients testing positive with NP samples, nasal and MT Ct values demonstrated high correlations with those Ct values of the NP samples. Patient-collected nasal or MT sampling may improve efficiency for COVID-19 testing while reducing the risk of exposure of the health workforce.
Publisher
Cold Spring Harbor Laboratory
Reference18 articles.
1. CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. 2020. [cited 2020 Mar 22] (https://www.cdc.gov/coronavirus/2019-ncov/index.html)
2. California Department of Public Health. CDPH Guidance for Prioritization of Patients for Laboratory Testing for COVID-19. [cited 2020 Mar 22](https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/GuidanceforPrioritizationofPatientsforLaboratoryTestingforCOVID19.aspx)
3. New York State Department of Health. COVID-19 Testing [cited 2020 Mar 22] (https://coronavirus.health.ny.gov/covid-19-testing)
4. Woolhouse M , Rambaut A , Kellam P. Lessons from Ebola: improving infectious disease surveillance to inform outbreak management. Science Translational Medicine; 7(307): 307rv5.
5. CDC. Interim Guidelines for Collecting, Handling and Testing Clinical Speciments from Persons for Coronavirus Disease 2019 (COVID-19). 2020. [cited 2020 Mar 21] (https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html)
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献